These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30738855)

  • 1. Reorganization of Septins Modulates Synaptic Transmission at Neuromuscular Junctions.
    Nurullin LF; Khuzakhmetova VF; Khaziev EF; Samigullin DV; Tsentsevitsky AN; Skorinkin AI; Bukharaeva EA; Vagin O
    Neuroscience; 2019 Apr; 404():91-101. PubMed ID: 30738855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction.
    Sons MS; Busche N; Strenzke N; Moser T; Ernsberger U; Mooren FC; Zhang W; Ahmad M; Steffens H; Schomburg ED; Plomp JJ; Missler M
    Neuroscience; 2006; 138(2):433-46. PubMed ID: 16406382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab3a deletion reduces vesicle docking and transmitter release at the mouse diaphragm synapse.
    Coleman WL; Bill CA; Bykhovskaia M
    Neuroscience; 2007 Aug; 148(1):1-6. PubMed ID: 17640821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction.
    Silinsky EM
    J Physiol; 2004 Jul; 558(Pt 2):389-401. PubMed ID: 15146054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vecuronium suppresses transmission at the rat phrenic neuromuscular junction by inhibiting presynaptic L-type calcium channels.
    Ji F; Han J; Liu B; Wang H; Shen G; Tao J
    Neurosci Lett; 2013 Jan; 533():1-6. PubMed ID: 23200725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic GABAB receptors mediate GABA inhibition of acetylcholine release in the rat neuromuscular junction.
    Malomouzh AI; Petrov KA; Nurullin LF; Nikolsky EE
    J Neurochem; 2015 Dec; 135(6):1149-60. PubMed ID: 26403151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse Effects of Noradrenaline and Adrenaline on the Quantal Secretion of Acetylcholine at the Mouse Neuromuscular Junction.
    Tsentsevitsky AN; Kovyazina IV; Bukharaeva EA
    Neuroscience; 2019 Dec; 423():162-171. PubMed ID: 31698023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of hydrogen sulfide (H2S) action on synaptic transmission at the mouse neuromuscular junction.
    Gerasimova E; Lebedeva J; Yakovlev A; Zefirov A; Giniatullin R; Sitdikova G
    Neuroscience; 2015 Sep; 303():577-85. PubMed ID: 26192092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine- and CaMKII-dependent release of endogenous CGRP induces an increase in acetylcholine quantal size in neuromuscular junctions of mice.
    Gaydukov AE; Balezina OP
    Brain Behav; 2018 Aug; 8(8):e01058. PubMed ID: 29978952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
    Flink MT; Atchison WD
    J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between Calcium Chelators and the Activity of P2X7 Receptors in Mouse Motor Synapses.
    Miteva A; Gaydukov A; Balezina O
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of transmitter release by synapsin II in mouse motor terminals.
    Samigullin D; Bill CA; Coleman WL; Bykhovskaia M
    J Physiol; 2004 Nov; 561(Pt 1):149-58. PubMed ID: 15388780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of All Synaptobrevin vSNAREs Blocks Evoked But Not Spontaneous Neurotransmitter Release at Neuromuscular Synapses.
    Liu Y; Sugiura Y; Südhof TC; Lin W
    J Neurosci; 2019 Jul; 39(31):6049-6066. PubMed ID: 31160536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the mechanisms underlying the non-quantal release of acetylcholine at the mouse neuromuscular junction.
    Vyskocil F; Nikolsky E; Edwards C
    Neuroscience; 1983 Jun; 9(2):429-35. PubMed ID: 6308511
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term in vivo modulation of synaptic efficacy at the neuromuscular junction of Rana pipiens frogs.
    Bélair EL; Vallée J; Robitaille R
    J Physiol; 2005 Nov; 569(Pt 1):163-78. PubMed ID: 16166159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5α-cholestan-3-one on the synaptic vesicle cycle at the mouse neuromuscular junction.
    Kasimov MR; Giniatullin AR; Zefirov AL; Petrov AM
    Biochim Biophys Acta; 2015 May; 1851(5):674-85. PubMed ID: 25725358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
    Yu SP; Van der Kloot W
    J Physiol; 1991 Feb; 433():677-704. PubMed ID: 1841963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine P2Y receptors in ATP-mediated regulation of non-quantal acetylcholine release from motor nerve endings of rat diaphragm.
    Malomouzh AI; Nikolsky EE; Vyskočil F
    Neurosci Res; 2011 Nov; 71(3):219-25. PubMed ID: 21821069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.